Cell test for detecting human chorionic gonadotropin

Claim 2

A diagnostic cell test for detecting human chorionic gonadotropin as evidence of cancer, comprising the steps of: (a) treating the cells to be tested with the specific antiserum to the beta-subunit of human chorionic ganadotropin, the antiserum having been raised in a host animal; (b) treating one portion of said cells with the antiserum to the gamma globulin of said host animal conjugated to fluorescein; (c) examining said one portion of cells under an utlra-violet light microscope for fluorescence; if fluorescence is found, the indirect fluorescein labeled antibody test is considered positive; if not, the indirect test is negative; (d) treating a second portion of cells with the antiserum to the gamma globulin of said host animal conjugated to peroxidase; (e) activating said peroxidase and then examining said second portion of said cells under a microscope for staining with peroxidase; if staining is found, the indirect peroxidase-labeled antibody test is considered positive; if not, the indirect test is negative; (f) if one indirect labeled antibody test is negative and the other indirect test is positive, repeat the indirect tests; and (g) analyzing the tests as follows; the diagnostic cell test for human chorionic gonadotropin is considered positive if both indirect labeled antibody tests are positive; if both indirect tests are negative or if one indirect test is positive and the other is negative, the cell test is considered negative, establishing that cancer is not present in the cells tested.

Claim 3

The diagnostic cell test defined in claim 1, including treating a further portion of said cells with a labeled antiserum which is not specific to one of said antiserum as a control and examining said portion under an ultra-violet light microscope and a conventional light microscope to determine the presence or absence of the label.

Claim 4

The diagnostic cell test defined in claim 1, including gently rinsing the cells after treatment with the antiserum to remove any excess antiserum.

Claim 5

The diagnostic cell test defined in claim 1, including preparing slides of the cells to be treated prior to treatment with the antiserum specific to the beta-subunit of human chorionic gonadotropin by impressing clear slides against the cell specimen to be tested, the cells remaining on the slide are then treated as claimed.

Claim 6

A diagnostic cell test for determining the absence of cancer in a cell specimen, by testing for human chorionic gonadotropin, comprising the steps of: (a) preparing slides of the cells to be tested having cell samples on clear slides; (b) treating the cell samples with an antiserum specific to the beta-subunit of human chorionic gonadotropin, said antiserum raised in a host animal; (c) gently rinsing the slides to remove any excess antiserum; (d) treating at least one slide with an antiserum specific to the gamma globulin of said host animal conjugated to fluorescein; (e) rinsing said one slide to remove any excess antiserum; (f) promptly examining said one slide with an ultra-violet microscope which passes the ultra-violet light through said cells; if fluorescein is found, the indirect fluorescein-labeled antibody test is considered positive; if no staining is found, this indirect test is negative; (g) treating a second slide with antiserum specific to the gamma globulin of said host animal conjugated to peroxidase; (h) rinsing said second slide to remove any excess antiserum; (i) activating said peroxidase; (j) examining said second slide with a microscope to determine whether peroxidase staining has occurred; the indirect peroxidase-labeled antibody test is considered positive if staining is found; if no staining is found, the test is negative; (k) the cell test for human chorionic gonadotropin is considered positive only if both indirect labeled antibody tests are positive; if both indirect antibody test are negative or if one indirect labeled antibody test is positive and the other is negative, the diagnostic cell test is negative for human chorionic gonadotropin, establishing that cancer is not present in the cells tested.

Claim 7

A diagnostic cell test for determining the absence of cancer in a cell specimen, by testing for human chorionic gonadotropin, comprising the steps of: (a) preparing slides of the cells to be tested having cell samples on clear slides; (b) treating the cell samples with an antiserum specific to the beta-subunit of human chorionic gonadotropin, said antiserum raised in a host animal; (c) gently rinsing the slides to remove any excess antiserum; (d) treating at least one slide with an antiserum specific to the gamma globulin of said host animal conjugated to fluorescein; (e) rinsing said one slide to remove any excess antiserum; (f) promptly examining said one slide with an ultra-violet microscope which passes the ultra-violet light through said cells; if fluorescein is found, the indirect fluorescein-labeled antibody test is considered positive; if no staining is found, this indirect test is negative; (g) treating a second slide with antiserum specific to the gamma globulin of said host animal conjugated to peroxidase; (h) rinsing said second slide to remove any excess antiserum; (i) activating said peroxidase; (j) examining said second slide with a microscope to determine whether peroxidase staining has occurred; the indirect peroxidase-labeled antibody test is considered positive if staining is found; if no staining is found, the test is negative; (k) the cell test for human chorionic gonadotropin is considered positive only if both indirect labeled antibody tests are positive; if both indirect antibody test are negative or if one indirect labeled antibody test is positive and the other is negative, the diagnostic cell test is negative for human chorionic gonadotropin, establishing that cancer is not present in the cells tested.

Claim 8

The diagnostic cell test defined in claim 5, wherein said slides are prepared by impressing clear slides against the cell specimen to be tested, then treating the cells on the slides as claimed.